Impact of Botulinum Toxin on Ocular Surface Parameters in Patients with Orbicularis Spasm: A Systematic Review and Meta-Analysis
Listen to this summary
This systematic review and meta-analysis aimed to clarify the effects of botulinum toxin (BTX) on ocular surface parameters in patients with orbicularis spasm, specifically assessing outcomes related to tear film stability and ocular symptoms. The findings indicate that BTX significantly improves ocular surface disease index scores and tear break-up time, while having neutral effects on Schirmer tests and reducing astigmatism. The authors suggest that these improvements may be linked to reduced involuntary eyelid contractions rather than direct biological effects of BTX on ocular surface physiology, highlighting the need for further research to explore these mechanisms.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from American journal of ophthalmology
View all →Sep 22, 2026 · American journal of ophthalmology
Incidence of De Novo Glaucoma and Ocular Hypertension After DMEK vs DSAEK: A Systematic Review and Meta-Analysis
Sep 19, 2026 · American journal of ophthalmology
Incidence, Prevalence, and Clinical Associations of Non-Infectious Pediatric Uveitis in the United States: A TriNetX Database Study
Sep 18, 2026 · American journal of ophthalmology
Predictors of Vision Loss and Surgical Intervention in Stevens-Johnson Syndrome: A Multicenter Nationwide Cohort Study
Sep 18, 2026 · American journal of ophthalmology
Photography-based Retinal Vasculometry and Visual Field Progression in Primary Open Angle Glaucoma
Sep 17, 2026 · American journal of ophthalmology
Regeneration and Replacement of the Corneal Endothelium: Advances in Cell Therapy, Tissue Engineering, Molecular and Pharmacologic Strategies
Sep 17, 2026 · American journal of ophthalmology
Ultra-Widefield OCT Mapping of Foveal and Optic Nerve Head Topography Within Posterior Staphyloma in Pathologic Myopia
More in Ophthalmology
View all →Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
Sep 22, 2026 · Lancet (London, England)
Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


